Filed July 4, 2024

Serial No. 79411781

Registered Jan. 20, 2026

Registration No. 8,105,646

Class Medicines, in particular medicines made from blood components, fractions and preparations, with said medicines being for the treatment of diseases and disorders of the blood; blood components, fractions and preparations, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood components, fractions and preparations for injection, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood components, fractions and preparations for automatic transplantation, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood components, fractions and preparations for transfusion, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood components, fractions and preparations for immunotherapy, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood components, fractions and preparations for autologous transfusion, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood, blood fractions and blood components for medical, therapeutic and prophylactic purposes, namely, blood for medical purposes, blood plasma, and blood substitutes for human use; blood plasma; cells for medical use, namely, blood cell preparations; health care substances and preparations, in particular for haematology, namely, pharmaceuticals for the treatment of blood diseases and disorders, blood for medical purposes, blood plasma, and blood substitutes for human use; finished medical products, namely, blood for human use and blood plasma; preparations for medical purposes, in particular haematology preparations, namely, pharmaceuticals for the treatment of blood diseases and disorders, blood for medical purposes, blood plasma, and blood substitutes for human use; immunotherapeutic and immunoprophylactic preparations, namely, pharmaceuticals for treating immunological diseases and disorders; living cells for medical purposes, namely, leukocyte preparations of white blood cells; Living cells and cell fragments for medical purposes, namely, platelet and red blood cell concentrates; blood plasma, namely, quarantine plasma and fractionated plasma; clinical medical reagents for processing human blood and blood components for use in blood transfusions and for extracorporeal blood processing stored in bags, bottles, syringes and similar containers for storing substances such as these for medical purposes; pharmaceutical products and haematology preparations for the treatment of blood and blood components, in particular infusion and transfusion solutions in the nature of blood, blood plasma, and blood substitutes for human use and pharmaceuticals for the treatment of blood diseases and disorders; pharmaceutical blood plasma preparations for the treatment of blood diseases and disorders; pharmaceutical blood preparations for the treatment of blood diseases and disorders; pharmaceutical blood products, namely, pharmaceuticals for the treatment of blood diseases and disorders; cell material for autotransplantation and autotransfusion, namely, cells for medical use; cell material for transplantation and transfusion, namely, cells for medical use; cell material for medical, therapeutic and prophylactic purposes, namely, cells for medical or clinical use; 005; 006; 018; 044; 046; 051; 052; 100; 101; 102; 100; 101; 100; 101

Case Type Trademark Service mark